Search

everythinglearnresearchcommunity

for

Search:↓

People with alopecia areata often have lower levels of vitamin D, zinc, and folate, but more research is needed to understand if supplements can help treat it.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

People with certain types of alopecia have a slightly higher risk of cancer, especially thyroid, bladder, and prostate cancers.

GLP-1 agonists may help treat certain skin conditions.

Polarized light therapy helps hair regrowth in alopecia areata patients.

Proretinal nanoparticles are a safe and effective way to deliver retinal to the skin.

Vitamin D is crucial for skin health and managing skin diseases.

Platelet-based therapies using a patient's own blood show promise for skin and hair regeneration but require more research for confirmation.

Platelet-rich plasma is beneficial in various plastic surgery applications, but more research is needed to standardize its use.

Some vitamin D analogs can thicken skin and reduce pore size like a common acne treatment, with one analog also affecting skin growth factors.

Anorexia Nervosa and Bulimia Nervosa are complex eating disorders with increasing incidence among young females, significant morbidity, and varying mortality rates, requiring more research for better treatment.

Using 120% sodium citrate in blood gives the best platelet recovery and enrichment.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

Papain cream removes hair better than papain gel, causing hair follicles to widen and skin to thicken.

People with atopic dermatitis have a higher risk of developing autoimmune diseases.

Higher IL-31 levels are linked to worse itching in chronic kidney disease patients.

The vitamin D receptor is crucial for bone health and affects various body systems, with mutations potentially leading to disease.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

Regenerative pharmacology, which combines drugs with regenerative medicine, shows promise for repairing damaged body parts and needs more interdisciplinary research.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Acitretin is effective for severe psoriasis and can be used long-term due to no immunosuppression, but must be carefully monitored for side effects and is not for pregnant women.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

The MATH+ protocol aims to improve COVID-19 outcomes using a combination of specific treatments.

HIV-positive patients, especially men who have sex with men, had a high rate of skin diseases and sexually transmitted infections.

Certain drugs may cause vitiligo, so patients should be monitored.

Platelets play a key role in the immune system and their lifespan and aging are important for developing new treatments.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.